SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001654954-18-002596
Filing Date
2018-03-15
Accepted
2018-03-15 16:06:22
Documents
4
Period of Report
2017-07-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K/A 35540
2 CERTIFICATE OF AMENDMENT gtbp_ex31.htm EX-3.1 2993
3 IMAGE gtbp_ex31000.jpg GRAPHIC 131931
4 IMAGE gtbp_ex31001.jpg GRAPHIC 75701
  Complete submission text file 0001654954-18-002596.txt   326208
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-08092 | Film No.: 18692412
SIC: 2834 Pharmaceutical Preparations